Yep, and pursuant to this meeting coming up, this spike doesn't look like a typical speculative-buying/positioning play. There's an extra kick of buying pressure, I would bet something has leaked-is leaking. I could be wrong. ANX stock is lurching ahead, though. Really pushing it... without a PR. That's good.
just keep in mind this is a face to face meeting request to find out exactly what FDA wants to grant approval. here will be no major announcement except for the clarification as to what we have to do to satisfy the FDA. With that said if we find out its a small amount of info missing that will be easy to add then it will look good going forward for approval chances. However if they are looking for a complete resubmission we could be stuck around this range for a few more months.
News 
Market Data 
Discover 
